Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immune Metabolic Associations in Psoriatic Arthritis Study

Trial Profile

Immune Metabolic Associations in Psoriatic Arthritis Study

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Apremilast (Primary)
  • Indications Plaque psoriasis; Psoriatic arthritis
  • Focus Therapeutic Use
  • Acronyms IMAPA
  • Most Recent Events

    • 07 Jun 2021 Results assessing effect of the PDE4 inhibitor apremilast on body weight and composition, glucose homeostasis, lipid profiles, and vascular function in psoriatic disease, and whether weight change correlated with therapeutic response, published in the Rheumatology.
    • 22 Nov 2019 Status changed from recruiting to completed.
    • 15 Jun 2019 Initial results (n=53) investigating the effects of PDE4 inhibition with apremilast on body weight, vascular function and disease activity presented at the 20th Annual Congress of the European League Against Rheumatism
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top